United States · FDA National Drug Code directory

XOLREMDI

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 83296-100_26bdd232-8068-9080-e063-6394a90aa084
Product NDC: 83296-100
Form: CAPSULE, GELATIN COATED
Composition / generic term: mavorixafor
Labeler: X4 Pharmaceuticals, Inc.
Marketing category: NDA
Marketing start / end (source format): 20240521
Source listing expiry: 20261231

Source-listed ingredients

MAVORIXAFOR — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

120 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-12) · 83296-100-12
60 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-60) · 83296-100-60
90 CAPSULE, GELATIN COATED in 1 BOTTLE (83296-100-90) · 83296-100-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →